Skip to content

A randomized, double-blind, placebo-controlled multicenter clinical study of Xifeng Huashi Granules in the treatment of diarrheal irritable bowel syndrome

A randomized, double-blind, placebo-controlled multicenter clinical study of Xifeng Huashi Granules in the treatment of diarrheal irritable bowel syndrome

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2000004143
Enrollment
Unknown
Registered
2020-12-08
Start date
2021-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diarrhea Predominant Irritable Bowel Syndrome

Interventions

Sponsors

Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. In line with the diagnostic criteria of WESTERN medicine IBS-D; 2. In line with the standard of TCM syndrome diagnosis of liver depression and spleen deficiency; 3. Aged 18-70 (including 18 and 70 years old) years; 4. Informed consent, voluntary test. The process of obtaining informed consent should comply with ethical principles.

Exclusion criteria

Exclusion criteria: 1. Patients with organic gastrointestinal diseases; 2. Patients with severe heart, liver, kidney, respiratory, blood and endocrine diseases; 3. Patients with mental illness and severe neurosis; 4. Women who are pregnant, breastfeeding or planning to have a pregnancy; 5. Those who had taken antibiotics or probiotics or gastrointestinal motility drugs within 1 month before the included test; 6. Poor compliance with medical advice, patients allergic to this drug; 7. Patients who are participating in other clinical studies.

Design outcomes

Primary

MeasureTime frame
Clinical overall efficacy evaluation;

Secondary

MeasureTime frame
psychological state;TCM syndromes;The recurrence rate;IBS-quality of life;IBS symptom severity;

Countries

China

Contacts

Public ContactLi Hui

Affiliated Hospital of Integrated Traditional and Western Medicine Nanjing University of Chinese Medicine

32260890@qq.com+86 17601558686

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026